Literature DB >> 15585004

Indications and contraindications of cell salvage.

Jonathan H Waters1.   

Abstract

Mesh：

Year:  2004        PMID： 15585004     DOI： 10.1111/j.0041-1132.2004.04176.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  7 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

3.  Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.

Authors:  Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2013-01-27

Review 4.  Transfusion management of trauma patients.

Authors:  Beth H Shaz; Christopher J Dente; Robert S Harris; Jana B MacLeod; Christopher D Hillyer
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

5.  Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.

Authors:  Grace Lim; Vladyslav Melnyk; Francesca L Facco; Jonathan H Waters; Kenneth J Smith
Journal:  Anesthesiology       Date:  2018-02       Impact factor: 7.892

6.  Intraoperative cell salvage in revision hip surgery.

Authors:  J M Herd; J J Joseph; M McGarvey; P Tsimbouri; A Bennett; R M D Meek; A Morrison
Journal:  Ann Med Surg (Lond)       Date:  2014-01-22

7.  Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section.

Authors:  I Sullivan; J Faulds; C Ralph
Journal:  Br J Anaesth       Date:  2008-05-30       Impact factor: 9.166
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.